FDMT
4D Molecular Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:58 PM EST
10.47USD-2.966%(-0.32)679,720
After-hoursNov 18, 2026 4:26:30 PM EST
10.46USD-0.096%(-0.01)
FDMT Financials
In Q3 FY 2026 (ended ), 4D Molecular Therapeutics, Inc. Common Stock (FDMT) reported revenue of $4.15M, net income of −$78.06M, operating cash flow of −$56.71M, and assets of $428.75M (filed ).
Loading financial statements…